These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 83413

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Studies on josamycin propionate. VIII. Further pharmacological studies (author's transl)].
    Takagi T, Nozaki Y, Tachikawa S, Usuda S.
    Jpn J Antibiot; 1974 Aug; 27(4):539-48. PubMed ID: 4474419
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y, Yuizono T, Tachibana K, Miyata T, Kito G, Miyano S.
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
    Nakamura T, Miura Y, Aihara K, Satoh H, Goto K, Tsumagari T.
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
    [Abstract] [Full Text] [Related]

  • 50. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M, Takasuna K, Kasai Y, Usui C, Kojima H.
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Pharmacodynamic actions of (S)-2-[4,5-dihydro-5-propyl-2-(3H)-furylidene]-1,3-cyclopentanedione (oudenone).
    Ozawa H, Koide T.
    Jpn J Pharmacol; 1976 Oct; 26(5):581-92. PubMed ID: 1003711
    [Abstract] [Full Text] [Related]

  • 53. [Pharmacological studies on Zingiber mioga (ZM) (1). General pharmacological effects of water extracts (author's transl)].
    Suzuki Y, Kajiyama K, Taguchi K, Hagiwara Y, Imada Y.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):669-82. PubMed ID: 540889
    [Abstract] [Full Text] [Related]

  • 54. [Psycopharmacological and general pharmacological studies of 7-chloro-1-cyclopropylmethyl-1, 3-dihydro-5-(2-fluorophenyl)-2H-1, 4-benzodiazepin-2-one (KB-509) (author's transl)].
    Sukamoto T, Aikawa K, Itoh K, Nose T.
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):447-68. PubMed ID: 7203280
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
    Shintani S, Toba Y, Suzuki S, Ninomiya S, Umezato M, Hiyama T.
    Arzneimittelforschung; 1985 Sep; 35(7A):1157-62. PubMed ID: 4074429
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [General pharmacology of BMY-28100].
    Goto A, Amano M, Sakai A, Hara M, Takahashi N.
    Jpn J Antibiot; 1990 Jul; 43(7):1289-309. PubMed ID: 2232158
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.